52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

Clinical trial NCT06689085 · RECRUITING

Trial details

NCT number: NCT06689085
Sponsor: Halozyme Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hypogonadism, Male

Start date: 2025-03-07
Primary completion: 2028-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.